Transcatheter or surgical aortic valve replacement in severely obese patients?

EuroIntervention 2022;18:e360-e361. DOI: 10.4244/EIJ-E-22-00021

Fausto Biancari
Fausto Biancari1,2, MD, PhD
1. Clinica Montevergine, GVM Care & Research, Mercogliano, Italy; 2. Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland
The prevalence of obesity is increasing worldwide1. Despite the perceived increased risks associated with being overweight, obese patients with cardiovascular diseases may have a comparable or even better prognosis than patients with a normal or low body mass index (BMI)2. Mariscalco et al3 demonstrated that patients with a BMI 25-40 kg/m2 had a lower risk of early adverse events after cardiac surgery compared to patients with lower BMI3. However, this benefit was lost in patients with BMI >40 kg/m2. Obese patients may also have better early and late outcomes after transcatheter aortic valve replacement (TAVR), as demonstrated by ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club

Latest news